Ani Pharmaceuticals (ANIP) Net Income (QoQ) (2011 - 2026)
Ani Pharmaceuticals (ANIP) Net Income (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15% |
| Dec 31, 2025 | 3.41% |
| Sep 30, 2025 | 212.22% |
| Jun 30, 2025 | -45.66% |
| Mar 31, 2025 | 252.72% |
| Dec 31, 2024 | 57.55% |
| Sep 30, 2024 | -958.07% |
| Jun 30, 2024 | -112.54% |
| Mar 31, 2024 | 1,480.16% |
| Dec 31, 2023 | -88.36% |
| Sep 30, 2023 | 58.60% |
| Jun 30, 2023 | 326.55% |
| Mar 31, 2023 | 134.23% |
| Dec 31, 2022 | 50.23% |
| Sep 30, 2022 | 42.35% |
| Jun 30, 2022 | 25.78% |
| Mar 31, 2022 | 16.72% |
| Dec 31, 2021 | -446.43% |
| Sep 30, 2021 | 68.80% |
| Jun 30, 2021 | -16,559.30% |